Under the terms of the transaction, DiagnoCure will also advance the development of certain genomic tests for Signal Genetics.
The two companies will create HPLC columns prepacked with BAC's Capture Select affinity ligand specificities on Life Technologies' Poros chromatography media and HPLC columns.
CLG will sell the StemArray products and services to its current customers and other companies and research institutions.
Enzo plans to validate the test in house and then seek approval in New York State to market it as an LDT.
The database will be available to researchers at 55 medical centers and universities supported by the Clinical and Translational Sciences Award from the National Institutes of Health.
The company will use GSG Mess-und Analysnegerate for marketing and distribution in Germany, Austria, and Switzerland.
Topin will create a marketing strategy around OnDose, prepare marketing materials, and conduct meetings to educate oncologists about the pharmacokinetic test.
QDx will develop, market, and process the QPredict Prostate Mitomic Test, which will be based on Mitomics' flagship mitochondrial DNA-based prostate cancer diagnostic.
The deal makes Bulldog the single source of Dualsystems' products in the US.
The agreement covers Conexio's SBT Resolver products, which are locus-specific PCR-based HLA sequencing-based typing reagents, and includes kits and analysis software.
A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.
A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.
NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.
In Nature this week: epigenetic factors that prevent healthy aging and more.